Static Chart NeuroSense Therapeutics Ltd.

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 23/05/2024 am IST			5-day change	1st Jan Change
1.24 ^USD	-1.59%		+10.71%	+57.96%

14/05	NeuroSense Partners with PhaseV for ALS Treatment Trial -- Shares Up	MT
07/05	NeuroSense Announces New Positive Data Analysis from PARADIGM Clinical Trial Demonstrating Statistically Significant Slowing of Disease Progression in High-Risk ALS Patients	CI

Duration

Period